IRIS
BRACCI, LUISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.188
EU - Europa 12.361
AS - Asia 6.302
SA - Sud America 1.077
AF - Africa 350
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 11
Totale 35.318
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.006
GB - Regno Unito 2.811
RU - Federazione Russa 2.382
CN - Cina 2.361
SG - Singapore 1.821
IT - Italia 1.500
IE - Irlanda 1.491
SE - Svezia 952
BR - Brasile 880
UA - Ucraina 877
DE - Germania 824
FR - Francia 636
VN - Vietnam 600
HK - Hong Kong 463
KR - Corea 339
FI - Finlandia 324
ZA - Sudafrica 196
IN - India 179
ES - Italia 155
CA - Canada 104
PL - Polonia 90
BD - Bangladesh 89
BE - Belgio 75
AR - Argentina 64
NL - Olanda 64
JP - Giappone 62
TR - Turchia 57
PK - Pakistan 50
NG - Nigeria 46
MX - Messico 45
IQ - Iraq 39
EC - Ecuador 33
CZ - Repubblica Ceca 32
IR - Iran 28
AT - Austria 26
VE - Venezuela 25
CI - Costa d'Avorio 24
AU - Australia 23
ID - Indonesia 23
PH - Filippine 22
CL - Cile 19
KE - Kenya 19
CH - Svizzera 18
UZ - Uzbekistan 18
MA - Marocco 17
AE - Emirati Arabi Uniti 16
CO - Colombia 15
IL - Israele 15
LT - Lituania 15
SA - Arabia Saudita 15
AZ - Azerbaigian 14
RO - Romania 14
EG - Egitto 13
JO - Giordania 13
PE - Perù 13
PY - Paraguay 12
EU - Europa 11
KZ - Kazakistan 11
TN - Tunisia 11
DZ - Algeria 10
RS - Serbia 9
EE - Estonia 8
KG - Kirghizistan 8
NP - Nepal 8
BG - Bulgaria 7
BO - Bolivia 7
BY - Bielorussia 7
DK - Danimarca 7
LB - Libano 7
AL - Albania 6
ET - Etiopia 6
JM - Giamaica 6
PA - Panama 6
BB - Barbados 5
HU - Ungheria 5
MY - Malesia 5
NZ - Nuova Zelanda 5
OM - Oman 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
AM - Armenia 4
DO - Repubblica Dominicana 4
LA - Repubblica Popolare Democratica del Laos 4
PT - Portogallo 4
CR - Costa Rica 3
CY - Cipro 3
GE - Georgia 3
GY - Guiana 3
HR - Croazia 3
SI - Slovenia 3
SN - Senegal 3
SV - El Salvador 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
GR - Grecia 2
HN - Honduras 2
LK - Sri Lanka 2
LV - Lettonia 2
Totale 35.291
Salva come PNG Salva come JPEG
Città #
Southend 2.469
Dallas 1.794
Dublin 1.473
Fairfield 1.437
Ashburn 1.118
Singapore 1.004
Chandler 875
Menlo Park 756
Woodbridge 707
Jacksonville 706
Moscow 671
Santa Clara 613
Houston 572
Beijing 552
Seattle 546
Wilmington 523
Siena 502
Ann Arbor 490
Cambridge 441
Hong Kong 440
San Jose 423
Hefei 412
Seoul 337
Princeton 270
The Dalles 228
Los Angeles 224
Nanjing 214
New York 210
Johannesburg 182
Ho Chi Minh City 156
Munich 146
Council Bluffs 142
Helsinki 138
Lauterbourg 137
Boardman 129
Hanoi 124
Milan 113
Málaga 112
San Mateo 109
Shanghai 109
Buffalo 93
Dong Ket 91
Nanchang 89
São Paulo 88
San Diego 82
Florence 77
Rome 71
Fremont 62
London 59
Hebei 58
Shenyang 58
Warsaw 58
Brussels 56
Dearborn 51
Orem 51
Tianjin 49
Washington 48
Abuja 46
Bengaluru 45
Frankfurt am Main 45
Chicago 43
Turku 43
Tokyo 42
Columbus 41
Redwood City 41
Toronto 40
Brooklyn 39
Kunming 38
Chennai 37
Jiaxing 37
Jinan 33
Phoenix 32
Changsha 30
Redondo Beach 30
Stockholm 30
Izmir 29
Amsterdam 27
Da Nang 27
Düsseldorf 27
Montreal 27
Denver 26
Dhaka 25
Lancaster 25
Rio de Janeiro 25
University Park 25
Abidjan 24
Atlanta 24
Haiphong 24
Zhengzhou 24
Brno 23
Manchester 23
Brasília 22
Hangzhou 22
Bagno a Ripoli 21
Belo Horizonte 21
Lappeenranta 21
Poplar 21
San Francisco 21
Guangzhou 20
Porto Alegre 20
Totale 24.031
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 372
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 363
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 361
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 360
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 357
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 353
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 353
Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment 352
A monoclonal antibody to a synthetic fragment of rabies virus glycoprotein binds ligands of the nicotinic cholinergic receptor 352
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 335
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 323
11β-hydroxysteroid dehydrogenase expression in first trimester human trophoblasts 320
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 318
A model of the rabies virus glycoprotein active site 312
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 311
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 309
Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist 307
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 306
A new NT4 peptide-based drug delivery system for cancer treatment 301
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 300
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 300
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 298
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 297
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 291
Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow-induced chemoresistance in acute leukemias 290
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 283
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 283
Analysis of the utility of a rapid vesicle isolation method for clinical strains of Pseudomonas aeruginosa 282
High performance liquid chromatography immunoaffinity purification of antibodies and antibody fragments 281
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 276
Oxidative stress-induced apoptosis in peripheral blood lymphocytes from patients with POLG-related disorders 275
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 274
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 272
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 272
Tumor imaging with tetrabranched neurotensin 267
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 264
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 262
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 262
HIV-1 gp 120 binding to nicotinig receptors 261
Affinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 260
Branched peptides as bioactive molecules for drug design 259
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 257
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 256
Purification of acidic synthetic peptides by high performance liquid chromatography using ammonium acetate buffer 251
Branched peptides for tumor diagnosis and therapy 248
Branched Neurotensin For Tumor Targeting 247
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 246
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 246
Antibacterial peptides and analogues thereof 245
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 244
Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein 242
Bioactive peptides from libraries 241
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 241
An antigenic determinant common to human chorionic somatomammotropin and human growth hormone revealed by limited proteolysis of immune complexes 240
Branched peptides as targeting agents for tumor imaging and therapy 237
Antigenicity of HIV-derived T-helper determinants in the context of carrier recombinant proteins: effect on T-helper cell repertoire selection 237
HIV-1 and human myelin proteins share an antigenic determinant 236
Nanoparticles exposing neurotensin tumor-specific drivers 236
Toxin-related antibodies with antimicrobial and antiviral activity 236
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 232
HPLC immunoaffinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 231
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 230
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 228
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 227
Biochemical filtering of a protein-protein docking simulation identifies the structure of a complex between a recombinant antibody fragment and alpha-bungarotoxin 227
Endogenous morphine modulates acute thermonociception in mice 225
Branched Neurotensin peptides for tumor personalized therapy 225
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 224
Branched multimeric peptides for tumor diagnosis and therapy 221
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 221
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 221
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 221
Immunogenicity of a free synthetic peptide: carrier-conjugation enhances antibody affinity for the native protein 220
Synthetic peptides in the form of dendrimers become resistant to protease activity 220
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 218
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 217
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 215
Identification of a neutralizing epitope on tosv gn glycoprotein 212
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 212
Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate 208
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 207
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 207
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 207
The antimicrobial peptide M33. An example of drug development 206
Branched neurotensin for tumor targeting 205
The development of antimicrobial peptides as new antibacterial drugs 204
A novel mimetic antigen eliciting protective antibody to Neisseria Meningitidis 202
Determination of antigen-specific immunoglobulin content in ascitic fluids and antisera 201
Tumor selective targeting by branched peptides 200
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 199
Binding of HIV-1 gp120 to the nicotinic receptor 199
Synthetic peptides of rubella E1 glycoprotein for serological assays 197
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 197
Molecular basis of branched peptides resistance to enzyme proteolysis 197
Three-dimensional computation of atom depth in complex molecular structures 196
The 208-222 region of the peplomer glycoprotein putative binding site of the rabiesvirus with the nicotinic acetylcholine receptor 195
NMR studies of lysozyme surface accessibility by using different paramagnetic relaxation probes 195
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 194
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 194
Neurotensin-derived branched peptides and uses thereof 192
Totale 25.509
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.885
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.885
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021872 0 0 0 0 0 0 0 0 0 364 235 273
2021/20222.227 155 261 150 228 131 82 108 109 97 244 202 460
2022/20233.150 184 321 405 438 340 600 60 254 239 141 124 44
2023/20242.355 79 76 234 116 101 679 812 50 9 43 17 139
2024/20254.674 96 223 523 267 566 261 169 302 365 170 524 1.208
2025/202610.580 854 1.582 1.503 1.406 2.274 444 1.129 397 430 561 0 0
Totale 35.637